Renodapt-STabletBiocon Limited Generic : Mycophenolic Acid | ₹ 400.00
180mg
10 |
Mycophenolic Acid(Myfortic) generic Renodapt-S is an immunosuppressant agent. It is used to prevent organ rejection in patients receiving allogeneic kidney transplants.
More Info about Mycophenolic Acid
Adult: Initial dose: 720 mg orally twice a day on an empty stomach, one hour before or two hours after food intake.
Geriatrics: 720 mg twice a day on an empty stomach, one hour before or two hours after food intake.
Pediatric: 400 mg/m2 twice a day (up to a maximum of 720 mg twice a day). Pediatric doses for patients with BSA <1.19 m2 cannot be accurately administered using currently available formulations of Myfortic tablets.
Common - Dizziness, stomach pain, vomiting, indigestion, nausea, diarrhea, weight loss, fatal pulmonary fibrosis, constipation, anemia, decrease in white blood cells.
Cardiovascular - Rapid heart rate, weak pulse.
Respiratory - Rapid and shallow breathing, dry cough, wheezing, shortness of breath, coughing up blood or vomit, inflammation of the esophagus.
Genitourinary - Increased urination.
Gastrointestinal - Rapid edema (swelling) of the skin, gastric ulcers, duodenal ulcers.
General - Lack of sleep.
It comes as a tablet, taken on an empty stomach and administered in combination with cyclosporine and corticosteroids.
Contraindicated in patients with known hypersensitivity, pregnancy and lactation.
Caution should be exercised in patients with history of active peptic ulcer, blood disorders, severe kidney impairment, polyomavirus infections, gastrointestinal disorders.
Patient may develop with increased risk of certain types of cancer, if it so consult with your doctor immediately.
Avoid exposure to sunlight/UV light.
Women taking this medication should seek contraceptive counseling.
Avoid excess dosage
Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container.